Lauren Poole/LinkedIn
Jan 1, 2026, 00:01
NIH R35 Grant Supports Dr. Lauren Poole’s Research on Fibrinogen and Immune Responses
NIEHS P30 Center for Environmental Exposures and Diseases sharede a post on LinkedIn:
“Congratulations to CEED member Dr. Lauren Poole for her recently awarded R35 grant from NIH/NIGMS! Her team will study fibrinogen – an abundant plasma protein and acute phase reactant – and how it interacts with leukocytes to direct inflammatory responses and disease. They are using novel in vivo and in vitro approaches to understand the fundamental processes regulating the expression and pro-inflammatory functions of fibrinogen, laying the foundation for safe and specific therapies targeting fibrinogen.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Feb 17, 2026, 16:34ISTH Names Five Global Recipients of 2026 Esteemed Career Awards
-
Feb 17, 2026, 16:16Flora Peyvandi: A Multicenter Initiative to Improve Guideline Adherence in Pediatric ITP
-
Feb 17, 2026, 16:14Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
-
Feb 17, 2026, 15:42Paul Wischmeyer: Nutrient Absorption in the GI Tract
-
Feb 17, 2026, 15:40Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
-
Feb 17, 2026, 15:38Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
-
Feb 17, 2026, 15:34Jeff June: When Safety Warnings Outlive the Evidence – What Statins Teach Us About Stroke Prevention and Biology
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH